Strategy Shows Promise for Psoriasis Remission in Early Study
The study is investigating whether high-dose IL-23 inhibition can target resident memory T cells and thereby induce long-term remission.
Source: medscape.com
Page 2 - Christopher Ritchlin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopher Ritchlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopher Ritchlin Today - Breaking & Trending Today
Study helps explain what drives psoriasis sev
Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.
Source: eurekalert.org
Why Not Both? Dual Biologics for RA and PsA
Previous clinical trials of dual biologic therapies have raised safety issues, but more recent, promising findings from clinical trials and case series have renewed interest in the treatment approach.
Source: medscape.com
Study Helps Explain What Drives Psoriasis Severity and Offers Clues as to How Disease May Spread to Other Body Parts
/PRNewswire/ -- Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told...
Source: prnewswire.com
Ixekizumab Significantly Benefits Patients with PsA Plus Nail, DIP Involvement
CCR East 2023 data show ixekizumab bettered adalimumab on measures of joint pain and quality of life in patients with PsA and concomitant nail plus DIP involvement.
Source: hcplive.com